# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-115361
Filing Date
2024-11-07
Accepted
2024-11-07 16:47:06
Documents
27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm2427808d1_8k.htm | DEFA14A | 25671
2 | EXHIBIT 99.1 | tm2427808d1_ex99-1.htm | EX-99.1 | 38470
3 | GRAPHIC | slide_001.jpg | GRAPHIC | 61439
4 | GRAPHIC | slide_002.jpg | GRAPHIC | 214850
5 | GRAPHIC | slide_003.jpg | GRAPHIC | 138499
6 | GRAPHIC | slide_004.jpg | GRAPHIC | 148235
7 | GRAPHIC | slide_005.jpg | GRAPHIC | 142970
8 | GRAPHIC | slide_006.jpg | GRAPHIC | 179743
9 | GRAPHIC | slide_007.jpg | GRAPHIC | 38985
10 | GRAPHIC | slide_008.jpg | GRAPHIC | 168272
11 | GRAPHIC | slide_009.jpg | GRAPHIC | 143696
12 | GRAPHIC | slide_010.jpg | GRAPHIC | 133250
13 | GRAPHIC | slide_011.jpg | GRAPHIC | 162981
14 | GRAPHIC | slide_012.jpg | GRAPHIC | 151080
15 | GRAPHIC | slide_013.jpg | GRAPHIC | 181864
16 | GRAPHIC | slide_014.jpg | GRAPHIC | 120208
17 | GRAPHIC | slide_015.jpg | GRAPHIC | 164002
18 | GRAPHIC | slide_016.jpg | GRAPHIC | 143093
19 | GRAPHIC | slide_017.jpg | GRAPHIC | 146641
20 | GRAPHIC | slide_018.jpg | GRAPHIC | 43820
21 | GRAPHIC | slide_019.jpg | GRAPHIC | 136043
22 | GRAPHIC | slide_020.jpg | GRAPHIC | 169231
23 | GRAPHIC | slide_021.jpg | GRAPHIC | 31950
24 | GRAPHIC | slide_022.jpg | GRAPHIC | 123839
25 | GRAPHIC | slide_023.jpg | GRAPHIC | 116793
26 | GRAPHIC | slide_024.jpg | GRAPHIC | 81366
27 | GRAPHIC | slide_025.jpg | GRAPHIC | 51139
| Complete submission text file | 0001104659-24-115361.txt |  | 4467250

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36177 | Film No.: 241436717
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)